A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform

Malczyk, Anna; Kupke, Alexandra; Prüfer, Steffen; Scheuplein, Vivian; Hutzler, Stefan; Kreuz, Dorothea; Beißert, Tim; Bauer, Stefanie; Hubich-Rau, Stefanie; Tondera, Christiane; Shams Eldin, Hosam; Schmidt, Jörg; Vergara‐Alert, Júlia; Süzer, Yasemin; Seifried, Janna; Hanschmann, Kay-Martin; Kalinke, Ulrich; Herold, Susanne; Şahin, Uğur; Cichutek, Klaus; Waibler, Zoe; Eickmann, Markus; Becker, Stephan; D. Mühlebach, Michael

doi:10.1128/jvi.01815-15

Public

A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform

Published in Journal of Virology • Sep 10, 2015

Authors:

Anna Malczyk

Alexandra Kupke

Steffen Prüfer

Abstract

UNLABELLED: In 2012, the first cases of infection with the Middle East respiratory syndrome coronavirus (MERS-CoV) were identified. Since then, more than 1,000 cases of MERS-CoV infection have been confirmed; infection is typically associated with considerable morbidity and, in approximately 30% of ...

Subject

Virology

Biology

Recombinant DNA

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!